IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Quartuccio, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 540
NA - Nord America 302
EU - Europa 217
SA - Sud America 208
AF - Africa 21
OC - Oceania 2
Totale 1.290
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 285
SG - Singapore 222
BR - Brasile 174
CN - Cina 95
HK - Hong Kong 70
VN - Vietnam 68
RU - Federazione Russa 38
DE - Germania 34
IT - Italia 34
FI - Finlandia 27
TR - Turchia 23
GB - Regno Unito 18
AR - Argentina 14
PL - Polonia 13
BD - Bangladesh 11
MX - Messico 11
NL - Olanda 10
AT - Austria 8
ZA - Sudafrica 8
EC - Ecuador 7
IN - India 7
JP - Giappone 6
MA - Marocco 6
EG - Egitto 5
IE - Irlanda 5
IQ - Iraq 5
PK - Pakistan 5
UA - Ucraina 5
UZ - Uzbekistan 5
CA - Canada 4
CO - Colombia 4
ID - Indonesia 4
PE - Perù 4
SE - Svezia 4
AZ - Azerbaigian 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
ES - Italia 3
VE - Venezuela 3
AU - Australia 2
FR - Francia 2
JO - Giordania 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 1.290
Salva come PNG Salva come JPEG
Città #
Singapore 72
Hong Kong 70
Beijing 37
Ho Chi Minh City 32
Ashburn 25
Helsinki 23
Istanbul 20
Los Angeles 18
São Paulo 16
Hanoi 15
New York 13
The Dalles 13
Warsaw 12
Moscow 11
Munich 11
Redondo Beach 11
Romola 11
Buffalo 10
Nuremberg 9
Curitiba 7
Johannesburg 7
San Francisco 7
Shanghai 7
Brooklyn 6
Chicago 6
Tokyo 6
Dublin 5
Milan 5
Phoenix 5
Poplar 5
Tashkent 5
Biên Hòa 4
Brasília 4
Cairo 4
Charlotte 4
Dallas 4
Faisalabad 4
Lappeenranta 4
Porto Alegre 4
Rio de Janeiro 4
Salt Lake City 4
Stockholm 4
Amsterdam 3
Atlanta 3
Baghdad 3
Baku 3
Belo Horizonte 3
Brno 3
Bắc Ninh 3
Caxias do Sul 3
Chennai 3
Denver 3
Dhaka 3
Guangzhou 3
Haiphong 3
João Pessoa 3
Pescara 3
Santa Clara 3
Vienna 3
Zhengzhou 3
Amman 2
Betim 2
Buenos Aires 2
Cleveland 2
Da Nang 2
Dalian 2
Don Torcuato 2
Falkenstein 2
Fortaleza 2
Frankfurt am Main 2
Hangzhou 2
Imbituba 2
Jacksonville 2
Jieyang 2
Lima 2
Magé 2
Manchester 2
Montreal 2
Newark 2
Nova Iguaçu 2
Orlando 2
Osasco 2
Portoviejo 2
Providence 2
Querétaro 2
Quezon City 2
Quito 2
Rabat 2
Resistencia 2
Ribeirão Preto 2
Salvador 2
Sorocaba 2
São José dos Campos 2
São Luís 2
Tunis 2
Vitória de Santo Antão 2
Zurich 2
Agrolândia 1
Alfenas 1
Aliquippa 1
Totale 675
Salva come PNG Salva come JPEG
Nome #
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 71
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 69
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 66
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys 65
COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis 64
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 63
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 63
Breakthrough SARS‑CoV‑2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID‑19 Vaccination in Autoimmune Disease (COVAD) study 61
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 61
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 61
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys 59
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 59
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 58
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 57
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 57
COVAD survey 2 long-term outcomes: unmet need and protocol 55
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 54
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment 53
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 49
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 47
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 46
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment 39
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study 37
Totale 1.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 13 0 1 2 0 3 5
2023/2024133 3 5 11 12 2 14 4 1 29 3 5 44
2024/2025487 7 20 17 45 24 48 73 67 41 35 84 26
2025/2026670 85 199 94 144 137 11 0 0 0 0 0 0
Totale 1.314